Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 IN LACTATED RINGER S IN PLASTIC CONTAINER versus NORMOSOL R AND DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 IN LACTATED RINGER S IN PLASTIC CONTAINER versus NORMOSOL R AND DEXTROSE 5 IN PLASTIC CONTAINER.
DEXTROSE 5% IN LACTATED RINGER'S IN PLASTIC CONTAINER vs NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides caloric support and increases serum glucose levels, while lactated Ringer's solution restores fluid and electrolyte balance. Lactate is metabolized to bicarbonate, buffering acidosis.
Normosol-R and Dextrose 5% is a balanced electrolyte solution with dextrose. The dextrose provides caloric support and prevents ketosis. The electrolytes (sodium, potassium, magnesium, chloride, acetate, gluconate) maintain osmotic balance and acid-base homeostasis. Acetate and gluconate serve as bicarbonate precursors to correct acidosis.
Intravenous infusion. Dose depends on patient's fluid and electrolyte needs. Typical adult infusion rate: 100-200 mL/hour. Maximum rate of dextrose infusion: 0.5 g/kg/hour to avoid hyperglycemia.
Intravenous infusion; dose depends on fluid and electrolyte needs. Typical adult dose: 500-1000 mL over 1-4 hours, may repeat based on clinical status.
None Documented
None Documented
Approximately 5-10 minutes for dextrose; lactated Ringer's components have variable half-lives: lactate 5-20 minutes, electrolytes follow renal clearance.
Dextrose: <15 minutes (rapid cellular uptake and metabolism). Electrolytes distribute and are excreted with kinetics dependent on renal function; no plasma half-life defined.
Renal: water and electrolytes are excreted renally; dextrose is metabolized to CO2 and water, with CO2 exhaled and water excreted renally. Biliary/fecal: negligible.
Renal elimination of water and electrolytes; dextrose is metabolized to CO2 and water, with <5% excreted unchanged. Biliary/fecal excretion negligible.
Category C
Category C
Intravenous Fluid
Intravenous Fluid/Electrolyte Solution